Protein tyrosine phosphatase 1B (PTP1B) is considered a potential target for the treatment of type II diabetes and obesity due to its critical negative role in the insulin signaling pathway. Here, PTPN1 is linked to obesity due to melanocortin 4 receptor deficiency.